These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 1527475)

  • 1. Comparison of the cytolytic effects in vitro on Trypanosoma brucei brucei of plasma, high density lipoproteins, and apolipoprotein A-I from hosts both susceptible (cattle and sheep) and resistant (human and baboon) to infection.
    Gillett MP; Owen JS
    J Lipid Res; 1992 Apr; 33(4):513-23. PubMed ID: 1527475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mice expressing human apolipoprotein A-I have sera with modest trypanolytic activity in vitro but remain susceptible to infection by Trypanosoma brucei brucei.
    Owen JS; Gillett MP; Hughes TE
    J Lipid Res; 1992 Nov; 33(11):1639-46. PubMed ID: 1464747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma brucei brucei: differences in the trypanocidal activity of human plasma and its relationship to the level of high density lipoproteins.
    Gillett MP; Owen JS
    Trans R Soc Trop Med Hyg; 1991; 85(5):612-6. PubMed ID: 1780989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutual self-defence: the trypanolytic factor story.
    Pays E; Vanhollebeke B
    Microbes Infect; 2008 Jul; 10(9):985-9. PubMed ID: 18675374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes.
    Thomson R; Molina-Portela P; Mott H; Carrington M; Raper J
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19509-14. PubMed ID: 19858474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the binding of human and bovine high-density lipoproteins by bloodstream forms of the African trypanosome, Trypanosoma brucei brucei.
    Gillett MP; Owen JS
    Biochim Biophys Acta; 1992 Feb; 1123(3):239-48. PubMed ID: 1536861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The trypanolytic factor-mechanism, impacts and applications.
    Wheeler RJ
    Trends Parasitol; 2010 Sep; 26(9):457-64. PubMed ID: 20646962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The trypanolytic factor of human serum.
    Pays E; Vanhollebeke B; Vanhamme L; Paturiaux-Hanocq F; Nolan DP; Pérez-Morga D
    Nat Rev Microbiol; 2006 Jun; 4(6):477-86. PubMed ID: 16710327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum.
    Vanhollebeke B; Nielsen MJ; Watanabe Y; Truc P; Vanhamme L; Nakajima K; Moestrup SK; Pays E
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4118-23. PubMed ID: 17360487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane permeabilization by trypanosome lytic factor, a cytolytic human high density lipoprotein.
    Harrington JM; Howell S; Hajduk SL
    J Biol Chem; 2009 May; 284(20):13505-13512. PubMed ID: 19324878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in the properties of the trypanolytic factor in normal human serum.
    Lorenz P; James RW; Owen JS; Betschart B
    Mol Biochem Parasitol; 1994 Mar; 64(1):153-64. PubMed ID: 8078518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of phospholipids in the cytotoxic action of high density lipoprotein on trypanosomes.
    Rifkin MR
    J Lipid Res; 1991 Apr; 32(4):639-47. PubMed ID: 1856609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
    Lecordier L; Vanhollebeke B; Poelvoorde P; Tebabi P; Paturiaux-Hanocq F; Andris F; Lins L; Pays E
    PLoS Pathog; 2009 Dec; 5(12):e1000685. PubMed ID: 19997494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I.
    Musliner TA; Long MD; Forte TM; Nichols AV; Gong EL; Blanche PJ; Krauss RM
    J Lipid Res; 1991 Jun; 32(6):917-33. PubMed ID: 1940624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes.
    Shiflett AM; Bishop JR; Pahwa A; Hajduk SL
    J Biol Chem; 2005 Sep; 280(38):32578-85. PubMed ID: 16046400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density-lipoprotein-independent killing of Trypanosoma brucei by human serum.
    Tomlinson S; Jansen AM; Koudinov A; Ghiso JA; Choi-Miura NH; Rifkin MR; Ohtaki S; Nussenzweig V
    Mol Biochem Parasitol; 1995 Mar; 70(1-2):131-8. PubMed ID: 7637693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human innate immunity against African trypanosomes.
    Pays E; Vanhollebeke B
    Curr Opin Immunol; 2009 Oct; 21(5):493-8. PubMed ID: 19559585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein.
    Hajduk SL; Moore DR; Vasudevacharya J; Siqueira H; Torri AF; Tytler EM; Esko JD
    J Biol Chem; 1989 Mar; 264(9):5210-7. PubMed ID: 2494183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection.
    Cuypers B; Lecordier L; Meehan CJ; Van den Broeck F; Imamura H; Büscher P; Dujardin JC; Laukens K; Schnaufer A; Dewar C; Lewis M; Balmer O; Azurago T; Kyei-Faried S; Ohene SA; Duah B; Homiah P; Mensah EK; Anleah F; Franco JR; Pays E; Deborggraeve S
    mBio; 2016 Apr; 7(2):e02198-15. PubMed ID: 27073096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein.
    Raper J; Nussenzweig V; Tomlinson S
    J Exp Med; 1996 Mar; 183(3):1023-9. PubMed ID: 8642243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.